Rift Valley Fever in Kenya

计划入组 250 人 · 首次发布于 2006 年 2 月 6 日

Safety and Immunogenicity Study of Rift Valley Fever Vaccine

计划入组 278 人 · 首次发布于 2008 年 1 月 2 日

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

计划入组 98 人 · 首次发布于 2009 年 3 月 26 日

RVFV-4s

hRVFV-4s (rift valley fever)

mRNA vaccine (rift valley fever)

SOUTH VALLEY UNIVERSITY

Egypt

NHS Forth Valley

United Kingdom

VALLEY WELDERS SUPPLY

United States

Rift Valley Fever Vaccine Enters Phase II Trials in Kenya Using Oxford's ChAdOx1 Platform

Afrigen Biologics Receives $6.2 Million Grant to Develop mRNA Rift Valley Fever Vaccine

CEPI Backs Phase II Trial of Rift Valley Fever Vaccine in Kenya